Indiana University is holding a clinical trial that analyzes the numerous factors that may contribute to functional bowel movement in healthy individuals. These factors include bowel symptoms, quality of life, and personal attributes.
Those who participate will complete 6 survey-based questionnaires online. Afterwards, they will be monitored on bowel symptoms and quality of life while participating in a 12-week therapy program. They also will record their bowel symptoms in a bowel diary and attend sessions with a GI psychologist.
- All sexes, ages 18 and older
- For the survey part of the study: Patients with a history of constipation, will be tested for dyssynergic defecation, a condition where there is a problem in the way certain nerves and muscles function in the pelvic floor
- For the monitoring section: Patients with a history of constipation with or without dyssynergic defecation and a positive history of EALs, a disease of obliterative vasculopathy or post-traumatic stress disorder (PTSD)
For the survey section:
- Currently hospitalized
For the monitoring section:
- Patients who have bipolar disorder
- Patients at risk for harm to themselves or others
- Unable to follow orders
- History of organic brain disease
- Patient using illicit substances
- Pregnant or postpartum patients
- Homeless or lacking sufficient social support for follow-up care
- Patients with acute stress disorder
- Patients with or severe PTSD
You may participate in this study at the University of Indiana in Indianapolis, Indiana 46202. If you may have any questions feel free to contact Carolyn J. Lockett at 317-278-9296 or at firstname.lastname@example.org. You may also contact Anita Gupta at 317-948-9227 or at email@example.com.
This study is sponsored by the University of Indiana with Andrea S. Shin as the Principal Investigator.
Clinical TrialsView All Clinical Trials
Efficacy and Safety of SYN-010 in IBS-C
Cedars-Sinai Medical Center is holding a clinical trial on the effectiveness of SYN-010 in the treatment of…
Linaclotide Safety and Efficacy in 2 to 5-Year-Olds
Allergen and Ironwood Pharmaceuticals Inc. are holding a clinical trial on the effectiveness of the drug…
Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation
The University of Michigan is testing the effectiveness of PEG 3350 (Miralax) and low FODMAP diet for people with…
Microbiome Analysis of Constipated Versus Non-Constipated Patients
This study uses HyGieaCare and biological microbiome therapy in an attempt to provide relief for people with…
Transcutaneous Electrical Acupoint Stimulation for Chronic Constipation
The University of California, Los Angeles, is studying transcutaneous…